Alyeska Investment Group
BOLD

Alyeska Investment Group’s Boundless Bio BOLD Stock Holding History

Alyeska Investment Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Hold
300,000
– – ﹤0.01% 596
2025
Q4 		$360K Hold
300,000
– – ﹤0.01% 567
2025
Q3 		$369K Hold
300,000
– – ﹤0.01% 566
2025
Q2 		$303K Hold
300,000
– – ﹤0.01% 533
2025
Q1 		$453K Hold
300,000
– – ﹤0.01% 471
2024
Q4 		$870K Hold
300,000
– – ﹤0.01% 501
2024
Q3 		$1.04M Hold
300,000
– – 0.01% 459
2024
Q2 		$1.16M Buy
300,000
+50,000
+20% +$478K 0.01% 455
2024
Q1 		$3.56M Buy
+250,000
New +$3.56M 0.02% 351

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Alyeska Investment Group's BOLD Position: Q1 2026 in Review

Alyeska Investment Group held its Boundless Bio (BOLD) position steady in Q1 2026 at 300,000 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #596.

Alyeska Investment Group first reported a position in BOLD in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.56M in Q1 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Alyeska Investment Group held 300,000 shares of Boundless Bio worth $330K as of Q1 2026.
  • Alyeska Investment Group left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #596 holding.
  • Alyeska Investment Group first reported a position in Boundless Bio in Q1 2024 and has held it in 9 quarters since.
  • Alyeska Investment Group's Boundless Bio position peaked at $3.56M in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.